FTSJ2 Antibodies

Santa Cruz Biotechnology delivers a wide array of FTSJ2 monoclonal antibodies for research in understanding FTSJ2 protein functions. FTSJ2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FTSJ2, also known as FTSJ2 RNA methyltransferase, plays a critical role in the modification of ribosomal RNA, which is essential for proper ribosome function and protein synthesis. FTSJ2 is involved in various cellular processes, including cell growth and differentiation, making it a significant target for studies related to cancer and other diseases. Understanding FTSJ2 function can provide insights into the molecular mechanisms underlying these conditions. Researchers can explore FTSJ2 expression patterns across different tissues and cell types using specific detection methods. Advanced imaging techniques combined with FTSJ2 monoclonal antibodies enable detailed visualization of subcellular localization. Investigating FTSJ2's role in RNA modification pathways opens new avenues for therapeutic development. Santa Cruz Biotechnology monoclonal antibodies for FTSJ2 support researchers worldwide in advancing our understanding of cellular processes and disease mechanisms.